Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $6.21 in the prior trading day, Neogenomics Inc (NASDAQ: NEO) closed at $6.42, up 3.38%. In other words, the price has increased by $3.38 from its previous closing price. On the day, 2.12 million shares were traded. NEO stock price reached its highest trading level at $6.56 during the session, while it also had its lowest trading level at $6.23.
Ratios:
Our goal is to gain a better understanding of NEO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 2.05. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.45.
On April 30, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 27 ’25 when Kelly Michael Aaron bought 5,000 shares for $7.60 per share. The transaction valued at 38,000 led to the insider holds 5,000 shares of the business.
Stone Warren bought 5,700 shares of NEO for $48,895 on May 12 ’25. The Pres & Chief Operating Officer now owns 108,280 shares after completing the transaction at $8.58 per share. On May 09 ’25, another insider, TETRAULT LYNN A., who serves as the Director of the company, bought 7,000 shares for $8.14 each. As a result, the insider paid 56,974 and bolstered with 7,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 826221888 and an Enterprise Value of 1045893888. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.23 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 1.556 whereas that against EBITDA is 1591.924.
Stock Price History:
The Beta on a monthly basis for NEO is 1.56, which has changed by -0.5770751 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, NEO has reached a high of $19.11, while it has fallen to a 52-week low of $6.08. The 50-Day Moving Average of the stock is -12.82%, while the 200-Day Moving Average is calculated to be -45.03%.
Shares Statistics:
The stock has traded on average 2.22M shares per day over the past 3-months and 1449450 shares per day over the last 10 days, according to various share statistics. A total of 128.36M shares are outstanding, with a floating share count of 126.92M. Insiders hold about 1.38% of the company’s shares, while institutions hold 96.33% stake in the company. Shares short for NEO as of 1751241600 were 4540073 with a Short Ratio of 2.04, compared to 1748563200 on 5484928. Therefore, it implies a Short% of Shares Outstanding of 4540073 and a Short% of Float of 4.8699997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0